• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球膀胱癌负担:更新。

The global burden of urinary bladder cancer: an update.

机构信息

Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.

出版信息

World J Urol. 2020 Aug;38(8):1895-1904. doi: 10.1007/s00345-019-02984-4. Epub 2019 Nov 1.

DOI:10.1007/s00345-019-02984-4
PMID:31676912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7363726/
Abstract

Bladder cancer is among the top ten most common cancer types in the world, with approximately 550,000 new cases annually. The highest burden of bladder cancer is currently falling on most developed communities across the globe. But with an anticipated shift in world demographics with growing and aging populations mainly on the African continent, and important shifts in exposure to different risk factors across the world, this is likely to change over the next decades. In this review, we provide an overview of the current incidence, mortality, prevalence, survival, risk factors and costs of bladder cancer worldwide.

摘要

膀胱癌是全球十大最常见癌症类型之一,每年约有 55 万新发病例。目前,膀胱癌的负担主要落在全球大多数发达国家。但随着全球人口结构的预期变化,主要是非洲大陆人口增长和老龄化,以及世界各地不同风险因素的暴露情况发生重要变化,这种情况在未来几十年可能会发生改变。在这篇综述中,我们概述了全球膀胱癌的发病率、死亡率、患病率、生存率、危险因素和成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/fe9ac89a0e59/345_2019_2984_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/1a7aaf6539fc/345_2019_2984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/eefe4ab10a41/345_2019_2984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/77174f2d923f/345_2019_2984_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/8b3390ceb281/345_2019_2984_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/a9a62ae706d7/345_2019_2984_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/fe9ac89a0e59/345_2019_2984_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/1a7aaf6539fc/345_2019_2984_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/eefe4ab10a41/345_2019_2984_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/77174f2d923f/345_2019_2984_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/8b3390ceb281/345_2019_2984_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/a9a62ae706d7/345_2019_2984_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420c/7363726/fe9ac89a0e59/345_2019_2984_Fig6_HTML.jpg

相似文献

1
The global burden of urinary bladder cancer: an update.全球膀胱癌负担:更新。
World J Urol. 2020 Aug;38(8):1895-1904. doi: 10.1007/s00345-019-02984-4. Epub 2019 Nov 1.
2
The present and future burden of urinary bladder cancer in the world.全球膀胱癌的当前及未来负担
World J Urol. 2009 Jun;27(3):289-93. doi: 10.1007/s00345-009-0383-3. Epub 2009 Feb 15.
3
The future burden of kidney and bladder cancers preventable by behavior modification in Australia: A pooled cohort study.澳大利亚通过行为改变预防肾脏和膀胱癌的未来负担:一项汇总队列研究。
Int J Cancer. 2020 Feb 1;146(3):874-883. doi: 10.1002/ijc.32420. Epub 2019 Jun 12.
4
Global Burden of Urologic Cancers, 1990-2013.全球泌尿生殖系统癌症负担,1990-2013 年。
Eur Urol. 2017 Mar;71(3):437-446. doi: 10.1016/j.eururo.2016.10.008. Epub 2016 Oct 28.
5
The global burden of urinary bladder cancer.膀胱癌的全球负担。
Scand J Urol Nephrol Suppl. 2008 Sep(218):12-20. doi: 10.1080/03008880802285032.
6
Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.204 个国家和地区 1990-2019 年膀胱癌全球、区域和国家负担及其归因风险因素:2019 年全球疾病负担研究的系统分析。
BMJ Glob Health. 2021 Nov;6(11). doi: 10.1136/bmjgh-2020-004128.
7
Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World.全球膀胱癌的流行病学、发病率、死亡率及其与发展指数的关系
Asian Pac J Cancer Prev. 2016;17(1):381-6. doi: 10.7314/apjcp.2016.17.1.381.
8
World Urologic Oncology Federation Bladder Cancer Prevention Program: a global initiative.世界泌尿外科肿瘤学联合会膀胱癌预防项目:一项全球倡议。
Urol Oncol. 2015 Jan;33(1):25-29. doi: 10.1016/j.urolonc.2014.07.017.
9
[Occupational bladder cancer in Japan and the world].[日本及全球的职业性膀胱癌]
Hinyokika Kiyo. 1989 Dec;35(12):1997-2002.
10
Epidemiology, Screening, and Prevention of Bladder Cancer.膀胱癌的流行病学、筛查与预防
Eur Urol Oncol. 2022 Dec;5(6):628-639. doi: 10.1016/j.euo.2022.10.003. Epub 2022 Nov 1.

引用本文的文献

1
Evaluating repeat transurethral resection after en bloc resection for non-muscle invasive bladder cancer.评估整块切除术后非肌层浸润性膀胱癌的重复经尿道切除术。
Ther Adv Urol. 2025 Sep 7;17:17562872251367555. doi: 10.1177/17562872251367555. eCollection 2025 Jan-Dec.
2
A fully implantable sensorized artificial urinary bladder to restore continence and fullness monitoring.一种用于恢复控尿和充盈监测的完全可植入的传感型人工膀胱。
APL Bioeng. 2025 Aug 28;9(3):036114. doi: 10.1063/5.0278500. eCollection 2025 Sep.
3
Mini-Cog test predicts need for rehabilitation intervention during weaning after radical cystectomy.

本文引用的文献

1
Bladder cancer survival: Women only fare worse in the first two years after diagnosis.膀胱癌生存率:仅在诊断后的头两年,女性的情况更糟。
Urol Oncol. 2019 Dec;37(12):853-861. doi: 10.1016/j.urolonc.2019.08.001. Epub 2019 Aug 31.
2
Smoking cessation, anxiety, mood and quality of life: reassuring evidences.戒烟、焦虑、情绪与生活质量:可靠证据
Minerva Med. 2014 Oct;105(5 Suppl 1):15-21. Epub 2014 Nov 14.
简易认知测试可预测根治性膀胱切除术后脱机期间康复干预的需求。
Curr Urol. 2025 Sep;19(5):347-352. doi: 10.1097/CU9.0000000000000294. Epub 2025 Jul 11.
4
Prognostic Utility of Combining VI-RADS Scores and CYFRA 21-1 Levels in Bladder Cancer: A Retrospective Single-Center Study.联合VI-RADS评分与CYFRA 21-1水平在膀胱癌中的预后价值:一项回顾性单中心研究
Curr Oncol. 2025 Jul 24;32(8):415. doi: 10.3390/curroncol32080415.
5
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.基于基因表达的膀胱癌淋巴结转移预测指标评估。
Bladder Cancer. 2025 Aug 21;11(3):23523735251370895. doi: 10.1177/23523735251370895. eCollection 2025 Jul-Sep.
6
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and management.膀胱小细胞癌:发病机制、临床表现及治疗综述
Bladder Cancer. 2025 Aug 18;11(3):23523735251370956. doi: 10.1177/23523735251370956. eCollection 2025 Jul-Sep.
7
Urinary bladder cancer needs more attention - recommendations for health care professionals and politicians in the European Union.膀胱癌需要更多关注——给欧盟医疗保健专业人员和政治家的建议
Nat Rev Urol. 2025 Aug 19. doi: 10.1038/s41585-025-01077-9.
8
Hydrogel technologies in andrology: advances in research and prospective applications.男性学中的水凝胶技术:研究进展与潜在应用
Front Pharmacol. 2025 Jul 28;16:1635007. doi: 10.3389/fphar.2025.1635007. eCollection 2025.
9
Risk Score Model of Aging-Related Genes for Bladder Cancer and Its Application in Clinical Prognosis.膀胱癌衰老相关基因风险评分模型及其在临床预后中的应用
JCO Clin Cancer Inform. 2025 Aug;9:e2500019. doi: 10.1200/CCI-25-00019. Epub 2025 Aug 8.
10
Nadofaragene firadenovec: a breakthrough in the field of bladder oncology.纳多福基因腺病毒载体:膀胱肿瘤学领域的一项突破。
Front Urol. 2023 Sep 15;3:1206398. doi: 10.3389/fruro.2023.1206398. eCollection 2023.